I think so Birdy. GPs would not necessarily be expected to know as much as we do about menopause since they are having to keep up with everything, but at least should be humble enough to accept that some patients will actually know more than they do. I can see it can make them feel uncomfortable....
"Mad pussy disease" I love this!!!
Tc - I quite agree that research needs to continue. The original trials for any form of medication do not seem to be lengthy, nor involved very large numbers of people from what I can see, for obvious reasons. However in order to progress once the medication is released onto the market, then further trials need to be carried out. There is the MHRA scheme for reporting adverse side effects but I don't think this scheme would pick up women who experienced a side effect more frequently than the trial found. Unfortunately accumulation of anecdotal evidence is not scientific even though individuals can vouch for a particualr effect. Whether funding can be found for future trials is another matter. It is a minefield!
Sheanie - did I see you are doing a presentation on HRT - that's great - are you a health professional? The best place to look for info first is probably not individual papers as these can be contradictory - but the review papers or consensus statements that have pulled together all the current info - and then refer back to the papers. There are seminal studies too! British Menopause Society would be the best starting point. The last paper produced about HRT which included breast cancer was 2016 - BMS and Women's Health Concern which you can find here:
https://journals.sagepub.com/doi/full/10.1177/2053369116680501. Also the NICE Guidelines - the detailed guidance which underpinned the recommendations. You can find this here:
https://www.nice.org.uk/guidance/ng23/evidence I haven't read any of this! I am sure there are later review papers too....
Michelemabelle - also re the vag prog thing. In fact contrary to what your gyane said, utrogestan is
manufactured to be taken orally or vaginally - it is only in the UK that it is only
licesned for oral use as part of HRT ( but the 200 mg capsules is now only licesned or rather marketed, for vaginal use for infertility. You will see the database of medicines (the base de donneespublique des medicaments) it is listed as: "UTROGESTAN 100 mg, capsule molle orale ou vaginale " - similarly for 200 mg. In the info it gives the indication for vaginal route, amongst other uses, if sidie effects are experienced with oral use:
"Dans toutes les autres indications de la progestérone, la voie vaginale représente une alternative à la voie orale en cas:
· d'effets secondaires dus à la progestérone (somnolence après absorption par voie orale). "
In all other indications of progesterone, the vaginal route respresents an alternative to the oral route in the case:
.. of side effects due to the progesterone (sleepiness after absorption by the oral route).
http://base-donnees-publique.medicaments.gouv.fr/affichageDoc.php'specid=61673424&typedoc=RHurdity x